Variable Continental Transmission Patterns Drive Disparate SARS-CoV-2 Lineage Emergence in Bolivia and Peru
Viruses · 2026-11-06 · 18 (11) · 1238
DOI: 10.3390/v18111238 ↗Abstract
Genomic surveillance of SARS-CoV-2 infections across South America remains inconsistent, limiting resolution of regional transmission dynamics. We compared the population structure and phylogeography of SARS-CoV-2 in Bolivia and Peru (18 June 2022–17 May 2024) to assess the cross-border connectivity and identify migration routes. We assembled a dataset of SARS-CoV-2 genomes sequenced for this study including 473 genomes from Bolivia and 273 genomes from Peru, as well as 3500 probability-proportional publicly available samples from other South American countries. Maximum likelihood and time-scaled phylogenies were used to infer clade structure and root ages. Discrete-trait phylogeographic models reconstructed continental transmission patterns, and mixed-effects regression identified over- and under-represented lineages within Bolivia and Peru. Viruses from Bolivia were enriched in Clade 24A (31.8% of samples) with several over-represented lineages (notably FE.1.1.1 and BF.1), whereas Peru also exhibited over- and under-represented lineages, such as XBB.2.6 and BF.39.1, respectively, and stronger integration with continental circulation. Phylogeographic analyses identified multiple well-supported directional exchanges between Peru and other South American countries (Peru ↔ Ecuador, Peru → Chile, Colombia → Peru). No directional transitions into or out of Bolivia exceeded our evidentiary threshold, and Bolivian genomes formed tighter phylogenetic clusters, consistent with more localized transmission. This study found that Bolivia and Peru differed substantially in regional connectivity during 2022–2024. Peru was embedded in broader continental transmission networks, whereas Bolivia showed patterns consistent with founder effects and sustained local transmission of a limited number of introduced lineages. These results underscore the value of expanded, geographically representative genomic surveillance and integrated epidemiological data to resolve the transmission pathways and guide regional public health responses.
EUVIMED